Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06595654

Treatment of Negative Symptoms of Schizophrenia by rTMS

Treatment of Negative Symptoms of Schizophrenia by Repetitive Transcranial Magnetic Stimulation: A Naturalistic Study

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
124 (estimated)
Sponsor
Centre hospitalier de Ville-Evrard, France · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to assess the effectiveness of rTMS on the negative symptoms of schizophrenia in real conditions. It will also provide a regulatory framework to rTMS treatments under these conditions. 4 types of rTMS protocols are proposed, allowing to adapt to patients and their tolerances.Treatment lasts between 2 and 4 weeks, with a follow-up period of 3 months after treatment to observe relapses.To assess the evolution of negative symptoms between baseline and the end of treatment, investigators use SANS (Scale for the Assessment of Negative Symptoms).

Conditions

Interventions

TypeNameDescription
OTHERrepetitive Transcranial Magnetic Stimulation* Patient is in a chair. * Hearing protection will be implemented. * The corresponding targeting method will be implemented. * The stimulation coil will be set up according to the indications of the targeting method. * A caregiver is present throughout the session. * After the session, the patient is re-assessed clinically for possible adverse effects. * If an adverse reaction is objectified, a doctor on site, is quickly mobilized.

Timeline

Start date
2023-06-09
Primary completion
2027-09-01
Completion
2028-03-01
First posted
2024-09-19
Last updated
2024-09-19

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT06595654. Inclusion in this directory is not an endorsement.